Accessibility Menu
 
NuCana Plc logo

NuCana Plc

(NASDAQ) NCNA

Current Price$1.54
Market Cap$6.62M
Since IPO (2017)-100%
5 Year-100%
1 Year-99%
1 Month-24%

NuCana Plc Financials at a Glance

Market Cap

$6.62M

Revenue (TTM)

$0.00

Net Income (TTM)

$29.32M

EPS (TTM)

$-134.61

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$1.54

Volume

1,460

Open

$1.53

Previous Close

$1.59

Daily Range

$1.45 - $1.56

52-Week Range

$1.45 - $268.00

NCNA News

No articles available.

NCNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NuCana Plc

Industry

Biotechnology

Employees

12

CEO

Hugh Stephen Griffith, MBA

Headquarters

Edinburgh, EH12 9DT, GB

NCNA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-194%

Return on Capital

-73%

Return on Assets

-98%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.62M

Shares Outstanding

4.16M

Volume

1.46K

Short Interest

0.00%

Avg. Volume

62.74K

Financials (TTM)

Gross Profit

$267.99K

Operating Income

$20.38M

EBITDA

$20.38M

Operating Cash Flow

$6.96M

Capital Expenditure

$0.00

Free Cash Flow

$6.96M

Cash & ST Invst.

$24.21M

Total Debt

$674.81K

NuCana Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$68.10K

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.62M

N/A

Market Cap/Employee

$330.87K

N/A

Employees

20

N/A

Net Income

$2.45M

-275.6%

EBITDA

$2.81M

-143.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$23.53M

+258.8%

Accounts Receivable

$1.76M

-62.1%

Inventory

$0.00

N/A

Long Term Debt

$654.85K

+459.7%

Short Term Debt

$19.96K

-72.7%

Return on Assets

-98.45%

N/A

Return on Invested Capital

-73.07%

N/A

Free Cash Flow

$930.00K

+87.6%

Operating Cash Flow

$930.00K

+87.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLGNCollPlant Biotechnologies Ltd.
$0.77+8.35%
MTVAMetaVia Inc.
$1.32+0.76%
CASICASI Pharmaceuticals, Inc.
$0.15+3.08%
CLSDClearside Biomedical, Inc.
$0.41+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.29-0.04%
TERNTerns Pharmaceuticals
$52.80+0.06%
ONDSOndas
$10.46-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.73+0.03%

Questions About NCNA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.